IDEX Other Non-Current Liabilities decreased by 4.6% to $192.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.3%, from $193.40M to $192.90M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -5.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $258.78M | $258.04M | $247.40M | $245.30M | $230.50M | $206.70M | $195.80M | $198.60M | $196.80M | $194.80M | $206.70M | $201.60M | $193.90M | $208.20M | $194.80M | $193.40M | $205.60M | $206.20M | $202.30M | $192.90M |
| QoQ Change | — | -0.3% | -4.1% | -0.8% | -6.0% | -10.3% | -5.3% | +1.4% | -0.9% | -1.0% | +6.1% | -2.5% | -3.8% | +7.4% | -6.4% | -0.7% | +6.3% | +0.3% | -1.9% | -4.6% |
| YoY Change | — | — | — | — | -10.9% | -19.9% | -20.9% | -19.0% | -14.6% | -5.8% | +5.6% | +1.5% | -1.5% | +6.9% | -5.8% | -4.1% | +6.0% | -1.0% | +3.9% | -0.3% |